Article Information
History
- October 29, 2020.
Article Versions
- Version 1 (October 25, 2020 - 03:24).
- You are currently viewing Version 2 of this article (October 29, 2020 - 19:54).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Antoine Joubert1,†,
- Fanny Andry1,2,3,†,
- Antoine Bertolotti1,2,4,
- Frédéric Accot1,
- Yatrika Koumar1,2,3,
- Florian Legrand1,3,
- Patrice Poubeau1,2,3,
- Rodolphe Manaquin1,2,3,
- Patrick Gérardin4,‡,* and
- Cécile Levin1,2,3,‡,*
- 1COVID-19 testing centre, Centre Hospitalier Universitaire de la Réunion, Saint Pierre, Reunion, France
- 2Department of Infectious Diseases and Tropical Medicine, Centre Hospitalier Universitaire de la Réunion, Saint Pierre, Reunion, France
- 3City to Hospital Outpatient Clinic for the care of COVID-19, Centre Hospitalier Universitaire de la Réunion, Saint Pierre, Reunion, France
- 4Centre for Clinical Investigation – Clinical Epidemiology (CIC 1410), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire de la Réunion, Saint Pierre, Reunion, France
- ↵*Correspondence: P. Gérardin, Center for Clinical Investigation (CIC1410), CHU Réunion, BP 350, 97448 Saint-Pierre Cedex – Reunion, France (patrick.gerardin{at}chu-reunion.fr); C. Levin, Department of Infectious Diseases and Tropical Medicine, CHU Réunion, BP 350, 97448 Saint-Pierre Cedex – Reunion, France (cecile.levin{at}chu-reunion.fr)
↵†‡ Contributed equally
Posted October 29, 2020.
Distinguishing non severe cases of dengue from COVID-19 in the context of co-epidemics: a cohort study in a SARS-CoV-2 testing center on Reunion island
